Skip to main content

Table 2 The estimated infarction size between AAβ and NO-AAβ group

From: Real-world use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/β-blocks in Chinese patients before acute myocardial infarction occurs: patient characteristics and hospital follow-up

The peak value of myocardial enzyme

Before PS match

p value

After PS match

p value

AAβ (n = 872)

NO-AAβ (n = 1833)

AAβ (n = 226)

NO-AAβ (n = 452)

pMyo (U/L)

69.4 (33–172)

75 (32.8–228)

0.12

75.2 (30.1–184.5)

75.9 (34.8–224.5)

0.32

pCK-MB (ng/mL)

28.3 (6–105)

47.9 (8.8–164)

< 0.001

31.9 (8.7–111)

57 (10–164)

0.02

pcTnI (ng/mL)

3.3 (0.64–11.0)

5.1 (1.2–17.1)

< 0.001

3.0 (0.72–10.0)

6.0 (1.4–21.1)

0.002

  1. AAβ ACEI/ARB/β-B, Myo myoglobin, CK-MB creatine kinase-myocardial band, cTnI cardiac troponin I, p peak value of
  2. p values for comparisons between the two groups. Significance level was 0.05